{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:22:04Z","timestamp":1771676524217,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.hoc.2007.11.001","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T09:58:40Z","timestamp":1200995920000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Relationship Between the Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia"],"prefix":"10.1016","volume":"22","author":[{"given":"Debra A.","family":"Hoppensteadt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine M.","family":"Walenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hoc.2007.11.001_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0038-1650316","article-title":"The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced-thrombocytopenia","volume":"75","author":"Arnout","year":"1996","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2007.11.001_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1055\/s-0038-1657563","article-title":"Antibody-mediated thrombosis","volume":"78","author":"Vermylen","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2007-1002434","article-title":"Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients","volume":"18","author":"Bick","year":"1992","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0889-8588(18)30275-2","article-title":"Anticardiolipin antibodies and thrombosis","volume":"6","author":"Bick","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.hoc.2007.11.001_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0889-8588(02)00103-X","article-title":"Antiphospholipid thrombosis syndromes","volume":"17","author":"Bick","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hoc.2007.11.001_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0889-8588(18)30279-X","article-title":"Acquired circulating anticoagulants","volume":"6","author":"Kunkel","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hoc.2007.11.001_bib7","series-title":"Thrombosis and hemorrhage","first-page":"817","article-title":"Antiphospholipid syndrome, lupus anticoagulants, and anticardiolipin antibodies","author":"Alving","year":"1998"},{"key":"10.1016\/j.hoc.2007.11.001_bib8","first-page":"78","article-title":"Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?","volume":"117","author":"Triplett","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.hoc.2007.11.001_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1055\/s-0038-1646476","article-title":"Lupus anticoagulant IgG's are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin","volume":"66","author":"Bevers","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib10","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: \u03b22-glycoprotein I\u00a0(apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hoc.2007.11.001_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","article-title":"Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease","volume":"336","author":"Matsuura","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2007.11.001_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajh.2830490414","article-title":"Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties","volume":"49","author":"Nakamura","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2007.11.001_bib13","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S. An explanation for their pathogenic mechanism","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.11.001_bib14","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1182\/blood.V83.9.2532.2532","article-title":"Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibits formation of antithrombin III-thrombin complexes","volume":"83","author":"Shibata","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.11.001_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/096120339600500511","article-title":"Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies","volume":"5","author":"Galli","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.hoc.2007.11.001_bib16","first-page":"416","article-title":"Thrombosis in systemic lupus erythematosus despite circulating anticoagulants","volume":"62","author":"Bowie","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.hoc.2007.11.001_bib17","first-page":"1916","article-title":"Clinical manifestations of the antiphospholipid syndrome","volume":"18","author":"Alarcon-Segovia","year":"1992","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.hoc.2007.11.001_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0038-1642698","article-title":"Protean clinical presentation of antiphospholipid-protein antibodies (APA)","volume":"74","author":"Triplett","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0038-1649577","article-title":"Anticardiolipin antibodies block the inhibition of 2 GPI of the factor Xa generating activity of platelets","volume":"70","author":"She","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0021-9150(87)90110-9","article-title":"Beta 2 glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation","volume":"63","author":"Nimpf","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hoc.2007.11.001_bib21","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1177\/096120339800700210","article-title":"Biology of endothelium","volume":"7","author":"Maruyama","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.hoc.2007.11.001_bib22","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients' active endothelial cells in vitro and in vivo","volume":"99","author":"Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2007.11.001_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0038-1661628","article-title":"IgG binding to endothelial cells in systemic lupus erythematosus","volume":"56","author":"LeRoux","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0038-1645039","article-title":"Cross reactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets","volume":"63","author":"Hasselaar","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib25","first-page":"317","article-title":"Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial damage","volume":"94","author":"Angles-Cano","year":"1979","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.hoc.2007.11.001_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/10245330500226860","article-title":"Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia","volume":"10","author":"Bidot","year":"2005","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.hoc.2007.11.001_bib27","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1002\/art.21437","article-title":"Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events","volume":"52","author":"Levy","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8565","key":"10.1016\/j.hoc.2007.11.001_bib28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(87)91470-X","article-title":"Anticardiolipin antibodies and occlusion of coronary artery bypass grafts","volume":"2","author":"Gavaghan","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2007.11.001_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-1001887","article-title":"Antiphospholipid antibodies in coronary artery disease: a review","volume":"20","author":"Baker","year":"1994","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.ATV.16.11.1319","article-title":"Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S","volume":"16","author":"Reverter","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hoc.2007.11.001_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<209::AID-AJH6>3.0.CO;2-#","article-title":"Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus","volume":"54","author":"Kaburaki","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2007.11.001_bib32","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1006\/bbrc.1994.2833","article-title":"Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V","volume":"205","author":"Nakamura","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hoc.2007.11.001_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0049-3848(94)90145-7","article-title":"Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia","volume":"75","author":"Matsuda","year":"1994","journal-title":"Thromb Res"},{"issue":"8214","key":"10.1016\/j.hoc.2007.11.001_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(81)92087-0","article-title":"Arterial thrombosis, intrauterine death and \u201clupus\u201d anticoagulant: detection of immunoglobulin interfering with prostacyclin formation","volume":"I","author":"Carreras","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2007.11.001_bib35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/s-0038-1649646","article-title":"Antiphospholipid antibodies enhance thrombin induced platelet activation and thromboxane formation","volume":"70","author":"Martinuzzo","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/1523-1747.ep12560947","article-title":"Effects of lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cells prostacyclin release and procoagulant activity","volume":"90","author":"Rustin","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.hoc.2007.11.001_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI117657","article-title":"On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies","volume":"95","author":"Smirov","year":"1995","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.hoc.2007.11.001_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0049-3848(95)00070-8","article-title":"Binding of autoimmune cardiolipin-reactive antibodies to heparin: a mechanism of thrombosis?","volume":"78","author":"Pengo","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.hoc.2007.11.001_bib39","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4049\/jimmunol.137.5.1532","article-title":"Antibody and immune complexes induce tissue factor production by human endothelial cells","volume":"137","author":"Tannenbaum","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.hoc.2007.11.001_bib40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood.V80.4.966.966","article-title":"Tumor necrosis factor induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface","volume":"80","author":"Ryan","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.11.001_bib41","first-page":"673","article-title":"The effects of lupus anticoagulant on the expression of tissue factor activity by cultured endothelial cells","volume":"65","author":"Brandt","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0037-1613441","article-title":"Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma","volume":"89","author":"Leurs","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s000180050067","article-title":"Annexin V, the regulator of phosphatidylserine-catalyzed\u00a0inflammation and coagulation during apoptosis","volume":"53","author":"Reutelingsperger","year":"1997","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.hoc.2007.11.001_bib44","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.hoc.2007.11.001_bib45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2491\/jjsth.16.623","article-title":"Heparin-induced thrombocytopenia and treatment with thrombin inhibitors","volume":"16","author":"Walenga","year":"2005","journal-title":"Japanese Journal of Thrombosis and Hemostasis"},{"key":"10.1016\/j.hoc.2007.11.001_bib46","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4 heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low molecular weight heparin: clinical implications for HIT","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2007.11.001_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0049-3848(99)00198-X","article-title":"A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery","volume":"97","author":"Lindhoff-Last","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.hoc.2007.11.001_bib48","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.95.5.1242","article-title":"Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery","volume":"95","author":"Bauer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2007.11.001_bib49","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjcard.2004.11.026","article-title":"Incidence of anti-platelet factor 4\/heparin antibody induction in patients undergoing percutaneous coronary revascularization","volume":"95","author":"Gluckman","year":"2005","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.hoc.2007.11.001_bib50","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1378\/chest.127.2_suppl.9S","article-title":"The pathophysiology of heparin-induced thrombocytopenia","volume":"127","author":"Kelton","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2007.11.001_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1656329","article-title":"PF4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib52","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib53","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1365-2141.1996.407945.x","article-title":"Pathogenicity of IgA and\/or IgM antibodies to heparin-PF4 complexes in patients with heparin-associated thrombocytopenia","volume":"92","author":"Amiral","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2007.11.001_bib54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V88.2.410.bloodjournal882410","article-title":"Presence of auto-antibodies to interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia","volume":"88","author":"Amiral","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2007.11.001_bib55","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1538-7836.2005.01560.x","article-title":"Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin","volume":"3","author":"Prechel","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2007.11.001_bib56","article-title":"Platelet-bound PF4 is targeted by HIT antibodies in the absence of heparin","volume":"5","author":"Prechel","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0049-3848(02)00397-3","article-title":"Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies","volume":"108","author":"Ahmad","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.hoc.2007.11.001_bib58","first-page":"83","article-title":"Laboratory methods for heparin-induced thrombocytopenia","author":"Prechel","year":"2004"},{"key":"10.1016\/j.hoc.2007.11.001_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0049-3848(97)00254-5","article-title":"Effect of glycoprotein IIb\/IIIa antagonists on the HIT serum induced activation of platelets","volume":"88","author":"Jeske","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.hoc.2007.11.001_bib60","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2007.11.001_bib61","first-page":"57","article-title":"Newer insights on the mechanism of heparin-induced\u00a0thrombocytopenia","volume":"30","author":"Walenga","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"10.1016\/j.hoc.2007.11.001_bib62","first-page":"29b","article-title":"Leukocyte activation in heparin-induced thrombocytopenia","volume":"96","author":"Jeske","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2007.11.001_bib63","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","article-title":"Induction of monocyte tissue factor expression by\u00a0antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia","volume":"97","author":"Pouplard","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.11.001_bib64","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0037-1615196","article-title":"Effect of SR121566A, a potent GPIIb\/IIIa antagonist, on the HIT serum\/heparin-induced platelet mediated activation of human endothelial cells","volume":"80","author":"Herbert","year":"1998","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2007.11.001_bib65","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1177\/10760296990050S114","article-title":"Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome","volume":"5","author":"Walenga","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2007.11.001_bib66","first-page":"37","article-title":"Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation","volume":"25","author":"Fareed","year":"1999","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.hoc.2007.11.001_bib67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/intimm\/14.2.121","article-title":"Anti-platelet factor 4\/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells","volume":"14","author":"Blank","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.hoc.2007.11.001_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2007.11.001_bib69","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V91.3.916","article-title":"Antibodies from patients with heparin-induced thrombocytopenia recognize different epitopes on heparin:platelet factor 4","volume":"91","author":"Suh","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.11.001_bib70","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1023\/A:1027372901367","article-title":"Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Walenga","year":"2000","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.hoc.2007.11.001_bib71","first-page":"3","article-title":"Catastrophic antiphospholipid antibody syndrome","volume":"65","author":"Shames","year":"2001","journal-title":"Conn Med"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2007.11.001_bib72","first-page":"I23","article-title":"Stroke associated with antiphospholipid antibodies","volume":"23","author":"Hess","year":"1992","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.hoc.2007.11.001_bib73","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.29.9.1759","article-title":"High prevalence of antiphospholipid antibodies in young patients with cerebral ischemia of undetermined cause","volume":"29","author":"Toschi","year":"1998","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.hoc.2007.11.001_bib74","first-page":"272a","article-title":"The role of CD40 ligand and anti-annexin V\u00a0antibodies in the pathophysiology of APS and HIT","volume":"96","author":"Baugh","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.11.001_bib75","first-page":"939","article-title":"Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndrome","volume":"97","author":"Lasne","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2007.11.001_bib76","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0037-1613220","article-title":"Heparin-platelet factor 4 induced antibodies in patients with either autoimmune or alloimmune antiphospholipid antibodies","volume":"88","author":"de Larranaga","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.11.001_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0961203306075562","article-title":"High prevalence of antibodies to platelet factor 4\u00a0heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia","volume":"16","author":"Martin-Toutain","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.hoc.2007.11.001_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"Van Kooten","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.hoc.2007.11.001_bib79","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1172\/JCI118643","article-title":"Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production","volume":"97","author":"Desai-Mehta","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2007.11.001_bib80","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI118855","article-title":"Increased expression of CD40 Ligand on systemic lupus erythematosus lymphocytes","volume":"98","author":"Koshy","year":"1996","journal-title":"J Clin Invest"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:49:58Z","timestamp":1760183398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985880700175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S088985880700175X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2007.11.001","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Relationship Between the Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2007.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}